Literature DB >> 2990204

Pyramidal tract deficits and polyneuropathy in hyperthyroidism, Combination clinically mimicking amyotrophic lateral sclerosis.

M Fisher, J E Mateer, I Ullrich, J A Gutrecht.   

Abstract

Generalized weakness, intermittent dysphagia, and a 40-pound weight loss developed in an elderly man over a six-month period. Examination revealed weakness, atrophy and fasciculations of extremity musculature, pseudobulbar speech, hyperactive upper extremity reflexes, and extensor toe signs without sensory loss. Results of electrodiagnostic studies were consistent with an axonal polyneuropathy. Endocrinologic results were compatible with hyperthyroidism. Radioiodine therapy resulted in resolution of clinical neurologic symptoms and signs within seven months. This case illustrates a previously undescribed concurrence of hyperthyroid associated polyneuropathy and pyramidal tract dysfunction that led to an initial clinical diagnosis of amyotrophic lateral sclerosis.

Entities:  

Mesh:

Year:  1985        PMID: 2990204     DOI: 10.1016/0002-9343(85)90231-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  Hyperthyroidism presenting as pyramidal tract disease.

Authors:  P J Shaw; D Bates; P Kendall-Taylor
Journal:  BMJ       Date:  1988-11-26

3.  Thyrotoxic Neuropathy: A rare cause of acute flaccid paraplegia.

Authors:  Aiman K Al-Wahaibi; Santosh Kumar; Ali Al-Risi; Farook Wali
Journal:  Sultan Qaboos Univ Med J       Date:  2018-01-10

4.  Acute thyrotoxic bulbar myopathy with encephalopathic behaviour: an uncommon complication of hyperthyroidism.

Authors:  Neeraja J Boddu; Sridhar Badireddi; Karl David Straub; John Schwankhaus; Rajani Jagana
Journal:  Case Rep Endocrinol       Date:  2013-06-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.